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Editorial
Looking back on the history of the psychosomatic medi-
cine in Japan, the focus of our scientific research and med-
ical practice was, at first, the elucidation of the
psychosomatic correlation between a patient's neurosis
and physical complaints. We then moved in the direction
of physical disorders – psychosomatic diseases – in which
psychosocial factors were closely involved in the onset
and course. We have always advocated the importance of
a comprehensive medical approach to the whole person
for such physical disorders.
We work from the viewpoint that a psychosomatic disease
is not present as a particular "mental" illness, but physical
disorders of daily life, "e.g., life-style related diseases".
Recently, however, because of rapid changes of the social
system, including the information-oriented society, psy-
chosomatic diseases as stress-related disease have
increased and the importance of psychosomatic medi-
cine/medical care is currently unprecedentedly high.
Elucidation of functional regulation systems, such as the
nervous-endocrine- immune system, which relate mind
and body, is an important theme in psychosomatic medi-
cine. Similarly, it is also important to elucidate how and
what kind of unbalanced or distorted "psycho-behavio-
ral" factors, such inadequate daily life habits and inappro-
priate stress coping styles, have influenced the
susceptibility to and the continuity of the diseases. This
further includes socio-cultural approaches that are epide-
miological, not solely focused on either the psychological
or behavioral aspect. When we turn our eyes to the diag-
nostic techniques used in psychosomatic medicine, dras-
tic progress has been made, as shown by the recent
research in the neuroscientific, genetic, and behavioral sci-
ences. Through empirical experience backed by these lines
of scientific evidence, psychosomatic medicine will be
able to further our aim of medical practice based on the
whole person concept.
Psychosomatic disease is, generally, not readily improved
by conventional medical approaches that are solely based
on the treatment of the physical aspects. This is because
bio/psycho/behavioral matters are strongly bound by
their interaction with various social and environmental
factors. We hope this online Internet journal of the Japa-
nese Society of Psychosomatic Medicine – BioPsychoSo-
cial Medicine, http://www.bpsmedicine.com/, will
contribute to the continued evolution of our field.
The general meeting of the 49th Japanese Society of Psy-
chosomatic Medicine was held last year in Sapporo
(Chairperson Tsukasa Koyama, Vice-chairperson Etsuji
Satohisa). "Progress in emotional stress research and psy-
chosomatic medicine" was advocated as a main theme,
and two special lectures were given; "Neuroscientific
study of affects and stress" by Taketoshi Ono and "Sex and
Sexagenarians" by Lorraine Dennerstein. Eight symposi-
ums were as follows; "The front line of mental health in
the work environment", "Adolescent psychosomatic dis-
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ease and an approach from psychosomatic medicine",
"Basics and practices of chronic pain", "Brain-gut correla-
tions related with Functional Dyspepsia", "Problems in
diagnosis and treatment of depression and their secrets in
daily practice", "The front line of research into eating dis-
orders" "Elucidation of psychosomatic diseases by neuro-
science", and "Cooperation between physicians and
psychologists involved in psychosomatic medical care in
the workplace". In addition, there were eleven educa-
tional seminars and a special program "Topics of psycho-
somatic medicine in the clinical areas – Obstetrics and
Gynecology, Dermatology, and Dentistry – ". We were
encouraged by the active participation of the attendees.
2009 is a turning point in that it has been 50 years since
the foundation of the Japanese Psychosomatic Society in
1959. This was a forerunner of the Japanese Society of Psy-
chosomatic Medicine. In commemoration of our estab-
lishment, the first joint meeting of the five Japanese
psychosomatic medicine societies and a commemorative
ceremony will be held in June at the Tokyo International
Forum (Yoshihide Nakai, administration meeting chair-
person).
This is the first time in our history that these five societies;
The Japanese Society of Psychosomatic Obstetrics And
Gynecology, The Japanese Society of Psychosomatic Inter-
nal Medicine, The Japanese Society of Psychosomatic
Dentistry, and The Japanese Society of Psychosomatic
Pediatrics will all meet under the leadership of The Japa-
nese Society of Psychosomatic Medicine. The theme will
be "Psychosomatic Medicine as Medical Care of The Near
Future". We hope to have lively interaction and promote
the spread psychosomatic medicine nationwide. It is our
hope that psychosomatic medicine will develop further as
a foundation of medicine and medical practice through-
out Japan and the world.
Herein, I will introduce trends of the past few years in
research fields; such as brain function imaging study,
genetic study, behavior science, and epidemiologic study;
into psychosomatic medicine, from point-of-view of
methods as the basis of clinical medicine and medical
care.
Brain function imaging study
Rapid progress in scientific technology has enabled the
non-invasive neuronal imaging of human brain function.
Especially, in recent years a staggering increase in func-
tional magnetic resonance imaging (fMRI) study has been
seen. fMRI is a method that is comparatively easy and
non-invasive, and its spacial resolution is superior to con-
ventional nuclear medicine technologies, such as positron
emission tomography (PET), single photon emission
computed tomography (SPECT), and electroencephalo-
gram (EEG).
Diversification of the modality
Trials of combinations of techniques to determine brain
activity have begun to emerge [1]: These do not solely
measure a specific brain function but at the same time
measure various physiological indexes of the autonomic
nervous system, such as pulse/skin conductance/electro-
myogram, to detect dynamic associations of the bodily
states with neural states. EEG has been used simultane-
ously with other neruoimaging techniques like fMRI, to
utilize the advantages of the high spatial resolution of
MRI and temporal resolution of EEG. The transcranial
magnetic stimulation method (TMS) is also used with
fMRI as a non-invasive method to temporarily suppress
the neuronal activity in a local region by electric stimula-
tion by a coil outside the head. The current trend in neu-
roscience to focus on brain function as one component of
a unified physical system, including the connection
between the bodily states and brain activity, seems
extremely well matched to the direction of psychosomatic
medicine. Furthermore, neuroimaging studies have been
done that compare psychosomatic patients and healthy
controls and that focus on the association of neuronal
states with individual differences in personality tenden-
cies (e.g., alexithymia associated with psychosomatic dis-
orders) [2-5].
The diversification of the context
Furthermore, there is a new direction of study that
includes a wider context than that of specific studies
focusing only on a certain disease or nervous system. For
example, a new field called 'social neuroscience' is spread-
ing rapidly in which neuroscience has begun to be applied
to probing highly advanced cognitive functions, such as
what kind of role a neuronal system plays in human social
interactions [6,7]. Thus, in the future, neurosciences may
also be applied to many issues of the mind-body correla-
tion advocated by psychosomatic medicine, especially to
the highly social level of issues in the bio-psycho-social
model, that are conventionally difficult to be addressed by
the neurosciences, for instance interpersonal relation-
ships.
Cerebral localization and networks
Recently, a movement has arisen that attempts to under-
stand the function of the brain both comprehensively and
integratively as a network [8]: This evolved from the
point-of-view that the various sites of the brain and the
wide variety of information from the body dynamically
form a complicated web of consciousness, recognition,
and feelings in a mutually influenced manner.BioPsychoSocial Medicine 2009, 3:1 http://www.bpsmedicine.com/content/3/1/1
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Recent study achievements
Some studies using a unique technique called "real time
fMRI" (rtfMRI) have been recently reported [9-12]. This
method resembles the "biofeedback" therapy that has
conventionally been used in psychosomatic medicine to
therapeutically give patients feedback on their distal phys-
iological signs. We can call rtfMRI "neurofeedback" in
which we use fMRI simultaneously feeding back to the
subjects the regional neural activity of the brain so that
they can learn to directly control activation of localized
regions by themselves -self-control. For example, when
subjects were trained and succeeded in achieving volun-
tary regulation of their right Brodmann's area (BA) 45,
extremely interesting results were found; the regional
activity increased and a significant improvement of accu-
racy was observed for the identification of emotional pro-
sodic intonation [12]. Based on these lines of evidence,
rtfMRI shows possibilities for use in rehabilitation
through training by non-invasive and non-pharmacologi-
cal means. A trial has just started into the clinical applica-
tions for chronic pain/drug dependency/depression and
the ability to support psychotherapy [9]. These trials seem
quite promising for future use in the field of psychoso-
matic medicine.
Conclusion
As research on the brain has advanced, we have found that
brain function is even more complicated than previously
thought. At the moment there are no clinical applications
immediately available, but in the near future the progress
of neuroscience shows promise for its clinical utility.
Genetic research
In psychosomatic medicine, we take into great account
the individuality of our patients. A wide variety of human
characteristics and individual differences are provided by
the environment and heredity. "Human Genetic Varia-
tion" was selected as the breakthrough of the year for
2007 by Science [13].
A new era of genome-wide association studies (GWAS)
has come and is resulting in systematic, well-powered,
genome-wide surveys for the identification of the risk
SNPs for complex diseases in the DNA sequence of the
human genome. Study has been facilitated by the interna-
tional HapMap project, equipped by the progress of
microarray technology, which has enabled the faster and
cheaper examination of millions of SNPs. Associated
genes have, in large scale studies, been successively identi-
fied for multifactorial diseases such as type II diabetes
mellitus [14].
Thus, genes and their function associated with individual
differences in susceptibility, variety of symptom, subtype,
course, and reactivity to a treatment can be elucidated.
This will shed light on factors that will help elucidate the
biomedical mechanism(s) of the mind-body relation-
ships
Genetic studies of the important, but common, diseases
in the area of psychosomatic medicine, including eating
disorders [15] and irritable bowel syndrome [16], are now
in progress, and related genes will be identified in the near
future.
Genetic elucidation in relation to the stress responsive-
ness of the hypothalamic – pituitary-adrenal system [17],
the autonomic nervous system, and personality traits is
currently being done in the Quantitative Trait Loci (QTL)
analysis to determine the gene locus responsible for meas-
urable, quantitative character. Studies from the viewpoint
of gene-environment interaction (GxE) have also
increased [18]. It is interesting how gene and psychosocial
factors are mutually associated and contribute to the onset
and the course of physical diseases.
Recently, an increasing number of studies in the area of
imaging genetics – the use of anatomical or functional
imaging technologies as intermediate phenotype (endo-
phenotype) to evaluate the role of genetic variation – have
shed light on the genetic basis as well as biological mech-
anisms involved in individual differences of cognition
and emotion [19].
In the following sections we highlight several reports of
genetic research done in the field of psychosomatic medi-
cine between the autumns of 2007 and 2008.
Eating disorders
An association between ED and polymorphism of the
brain-derived neurotrophic factor (BDNF) gene was
reported [15]. Mercader J M et al. examined transmission
disequilibrium with 371 sets of ED trios and parents in a
study of 151 Tag SNPs covering ten neurotrophin signal-
ing genes, including BDNF and its receptors, and found
significant association with the SNPs of the receptor
NTRK3  genes among ED patients. Individuals carrying
this SNP showed higher levels of NTRK3 expression in
lymphoblastoid cell lines. Furthermore, higher expression
of the orthologous murine Ntrkk3 gene was detected in
the hypothalamus of an anx/anx mouse model of ano-
rexia, showing synergetic epistatic interaction with the
mutation of the NGFB gene. These lines of evidence sug-
gested a certain role of the point neurotrophin signaling
genes to the susceptibility factors for EDs [20].
Irritable bowel syndrome
The 5-HT3s serotonin receptor type 3 subunit genes are
involved in intestinal tract motor – sensory function, and
the 5-HT3 receptor antagonist, alosetron, is effective inBioPsychoSocial Medicine 2009, 3:1 http://www.bpsmedicine.com/content/3/1/1
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the treatment of diarrhea predominant IBS (IBS-D).
Kapeller J et al. found that the mutation of the untrans-
lated regions (UTRs) of the HTR3E  serotonin receptor
type 3 subunit genes was strongly related to female IBS-D.
This is the first example indicating that this mutation
modified the adjustment of the gene expression by micro-
RNA [21].
Gene/environment interaction and stress reactiveness
Increased cardiovascular reactivity (CVR) to mental stress
influences the risk of cerebrovascular and heart diseases
and their clinical course. Williams RB et al. reported that
childhood low socioeconomic status (indexed by Father's
Education Level) and the more transcriptionally efficient
long (L) allele of a polymorphism of the serotonin trans-
porter gene promoter (5HTTLPR) enhance cardiovascular
reactivity to mental stress. However, there was no signifi-
cant interaction between 5HTTLPR polymorphism and
socioeconomic status; both worked additively [22].
Imaging genetics
Genetically driven variation in neurotransmitter function
and brain circuits involved in emotion have attracted our
attention [19]. Perlis RH et al. used fMRI and showed that
a significant differential activation in insula in response to
angry facial expressions is associated with the SNP near
the cAMP response element binding protein gene
(CREB1); the transcriptional control factor gene. CREB
has many functions in the regulation of learning and
memory, and plays a role in the brain structure related to
a reward and evasion. The Perlis group also reported that
the same SNP of the CREB1 is associated with overt/covert
anger expression. It is known that the insula forms a brain
network with the amygdale, orbitofrontal cortex, and
anterior cingulate gyrus, which have been implicated in
processing aversion, such as anger [23].
The role of genetic research in psychosomatic medicine
will be much increased in the future. Currently, when we
talk about individualized medicine (tailor-made medi-
cine), only genetic information comes to mind. Psychoso-
matic medicine, however, should aim at the realization of
a truly personalized medicine that is based on our com-
prehension of psychosocial/environmental and genetic
factors and their gene-environment interactions.
Behavioral science
What is behavioral science?
Behavioral science is considered to be an interdisciplinary
study using the methodology of various disciplines.
Behavioral science applied to the medical field is behavio-
ral medicine, which is defined as "the interdisciplinary
field concerned with the development and integration of
psychosocial, behavioral and biomedical knowledge rele-
vant to health and illness and the application of this
knowledge to prevention, etiology, diagnosis, treatment
and rehabilitation," as stated in the charter of the Interna-
tional Society of Behavioral Medicine (ISBM) (1990). We
here introduce distinguished reports on some important
topics presented since the autumn of 2007.
Association between coronary heart diseases and 
depression
Recently, the association between psychosocial factors
and susceptibility/prognosis of coronary heart disease has
regained attention [24]. In the autumn of 2007, guide-
lines on cardiovascular disease (CVD) prevention in clin-
ical practice by nine European societies were presented
that consider psychosocial factors as independent risk fac-
tors for CVD [25]. In particular, depression (including
major depressive disorder as well as depressive symp-
toms) is regarded as an important risk factor [24]. Several
articles have reported "the effects of the treatment of
depression on patient outcomes after myocardial infarc-
tion ".
Studies of the effect of pharmacotherapy
At present, there is controversy concerning the effect of
antidepressants on patients after myocardial infarction.
Although observational secondary analysis on morbidity
and mortality in post-myocardial patients who partici-
pated in the Enhancing Recovery in Coronary Heart Dis-
ease study (ENRICHD) indicated that the use of selective
serotonin reuptake inhibitors (SSRI) in depressed patients
reduced subsequent fatal cardiovascular event and mor-
tality than non-users [26], the Myocardial INfarction and
Depression-Intervention Trial (MIND-IT) showed that
SSRI did not give better prognosis in a placebo-controlled
trial [27]. However, as shown in the results of the second-
ary analysis of the MIND-IT [28], patients who were non-
responsive to treatment for depression following MI may
be associated with subsequent cardiac events.
Study of the effect of psychotherapy
In the above ENRICHD randomized trial, cognitive
behavior therapy (CBT) did not increase event-free sur-
vival or reduce subsequent cardiac events compared with
the usual care group [29]; however, the secondary analysis
of the ENRICHD randomized trial showed that CBT
homework adherence could improve depression in the
treatment of comorbid depression in those post-MI
patients [30].
Furthermore, for depression associated with mortality fol-
lowing MI, a distinguished study was reported in 2008;
only new onset depression following myocardial infarc-
tion predicts cardiac mortality, but not all depression does
so [31]. Thus, the subjects of investigation should be nar-
rowed down in future studies.BioPsychoSocial Medicine 2009, 3:1 http://www.bpsmedicine.com/content/3/1/1
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A new clinical assessment method in behavioral science
Recently, ecological momentary assessment (EMA) has
been proposed in the behavioral sciences as a reliable
method to assess and record events and subjective symp-
toms as well as physiological and behavioral variables in
natural settings. Computerized EMA, i.e. EMA using com-
puters as electronic diaries, has been developed [32] and
a symposium on EMA was held at the 10th International
Congress of Behavioral Medicine held in August of 2008.
Our group applied EMA using a watch-type computer
device for patients with tension-type headache and
revealed the importance of assessment of the phenomena
at the moment they occur in natural settings [33]. The
physical activity level was significantly reduced at the time
of headache exacerbation [34].
To explore the future direction of EMA study, it is prefera-
ble not only to simply record subjective symptoms but
also to record an index of objectivity such as physical
activity at the same time, and also to use EMA for interven-
tion studies. Regarding the former direction, our group
reported that patients with depression were statistically
different from healthy people in terms of the pattern of
active period duration with physical activity [35]. By ana-
lyzing the behavioral organization of mice with depres-
sion experimentally similar to that of humans, we found
similar results across species [36]. Regarding the latter, a
pilot study using online digital assistance of patients with
migraine combined mobile electronic diary monitoring of
symptoms with direct online coaching of preventive
health behavior [37]. Further development is expected.
Epidemiologic studies
Several interesting reports have recently been published
that add to the epidemiologic findings of stress-related
diseases. The final qualifying soccer games of the FIFA
World Cup are being held now, in January 2009, and
many of you may remember having excitedly watched the
2006 FIFA World Cup games, either in person in Germany
or through television. During the one-month period of
the last FIFA World Cup, an epidemiological survey was
conducted to assess the daily number of patients trans-
ported to emergency departments at 15 major German
hospitals for the treatment of coronary heart diseases [38].
For the seven matches involving the German team, the
daily number of patients visiting the emergency depart-
ments for acute coronary heart diseases was significantly
increased on six of the seven match days, exclusive of the
day when the German team played at the bronze medal
match after missing the championship final. The odds
ratio of such events on the six days was around 2, when
compared to the control period. Thus, it was concluded
that cardiovascular events were caused by the excitement
of viewing the World Cup soccer games. In lectures on
psychosomatic medicine, Japanese students and practi-
tioners have often been presented case studies showing
that blood pressure is elevated by watching close Sumo
matches and that some hypertensive patients suffer from
myocardial infarction because of this excitement. It is
interesting that such phenomenon were confirmed epide-
miologically in Germany.
Related to the topic of cardiovascular diseases, the Japa-
nese Ministry of Health, Labour, and Welfare, since April,
2008, has required a specific health checkup for patients
and persons at high of metabolic syndrome. This checkup
covers 57 million people aged 40–74 years old who par-
ticipate in public health insurance plans, and many enter-
prises and local government offices are busy to meet the
regulations. It is important to clarify if or to what extent
mental health conditions are associated with metabolic
syndrome and individual metabolic risk factors like obes-
ity and hypertension [39,40]. Because there have been
numerous studies examining the type A personality over
the past decades, almost all researchers believe there is an
association between cardiovascular events and anger/hos-
tility. However, epidemiological reports have just begun
to be published showing that metabolic syndrome is asso-
ciated with depression and anxiety as well. For example, a
depressive state, but not anxiety, had a significant, posi-
tive association with metabolic syndrome in a study of
Japanese male workers [41]. These results will need to be
confirmed in further studies.
In the research of psychosomatic medicine, we first
should establish reliable and valid quantitative measure-
ments for the assessment of "psychosocial stress" to eval-
uate quantitatively the effects of psychosocial stressors on
the mind/body. In this sense, the maximum or ultimate
psychosocial stress is that "a person experiences, wit-
nesses, or is confronted with an event or events that
involve actual or threatened death or serious injury, or a
threat to the physical integrity of self or others". Post-trau-
matic stress disorder (PTSD) is an anxiety disorder
induced by such an ultimate, psychosocially stressing
traumatic event, and it is important to assess PTSD symp-
toms precisely to understand stress-related disorders.
PTSD patients are distressed by clinically characteristic
symptoms like nightmares that recall the event for
months, hyper vigilance of the autonomic nervous sys-
tem, and fright reaction and insomnia. However, the psy-
chophysiological mechanism of PTSD still remains
unclear. So far, there are several important epidemiologi-
cal studies of PTSD triggered by recent traumatic events,
including the September 11 tragedy, the Iraq War, and
man-made and natural disasters, such as large earth-
quakes in many parts of the world [42-44]. Also, there is
an interesting report that prior traumatic experience
increases the risk of PTSD after a subsequent trauma [45].BioPsychoSocial Medicine 2009, 3:1 http://www.bpsmedicine.com/content/3/1/1
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It is important to conduct routine, systematic mental
health after exposure to such disasters as great earth-
quakes and accidents. In addition, we, the researchers,
should report evidence of the effectiveness of such sys-
temic interventions done in our clinical practice.
It is a painful experience to face the aftermath of death.
Feelings are paralyzed temporarily and bereavement reac-
tions occur when a person loses a close relative or a
beloved one [46]. For some people, the depressive state
does not recover and lasts for more than a month. It has
become a social concern in Japan that the annual number
of suicides has been more than 30,000 for the past ten
years [47]; consequently, mental health care has become
an important issue, not only for the suicide victim but also
for the bereaved family. In clinical practice, we must keep
a sharp insight into the risks of depression and suicide for
patients we see in our daily practice. We must preserve the
mind of embrace, carefully listening to a psychologically
shocked patient as well [48]. We believe that the accumu-
lation of our steady efforts will result in great power and
contribute to the progress of the public health of the
whole nation [49].
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